Literature DB >> 24136077

IRF4(-/-)Vh11 mice: a novel mouse model of CLL.

Yiming Zhong1, John C Byrd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24136077     DOI： 10.1182/blood-2013-08-521120

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.

Authors:  Jillian A Bristol; Joshua Brand; Makoto Ohashi; Mark R Eichelberg; Alejandro Casco; Scott E Nelson; Mitchell Hayes; James C Romero-Masters; Dana C Baiu; Jenny E Gumperz; Eric C Johannsen; Huy Q Dinh; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2022-04-26       Impact factor: 7.464

2.  IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.

Authors:  Rossana Maffei; Stefania Fiorcari; Stefania Benatti; Claudio Giacinto Atene; Silvia Martinelli; Patrizia Zucchini; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  Leukemia       Date:  2021-02-23       Impact factor: 11.528

3.  Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia.

Authors:  Vipul Shukla; Ashima Shukla; Shantaram S Joshi; Runqing Lu
Journal:  Oncotarget       Date:  2016-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.